e-Article

	o	ㅋ	ㄱ	ㅅ	ㅈ	ㅌ	ㄷ	촉	ㄴ	ㅎ	ㅂ	ㅃ	ㅁ	야	ㄹ	와
ㅏ	あ a	ぁ	か ka	が ga	さ sa	ざ za	た ta	だ da		な na	は ha	ば ba	ぱ pa	ま ma	や ya	ゃ lya	ら ra	わ wa	ゎ lwa	ん n
l	い i	ぃ	き ki	ぎ gi	し si	じ zi	ち ti	ぢ di		に ni	ひ hi	び bi	ぴ pi	み mi			り ri
ㅜ	う u	ぅ	く ku	ぐ gu	す su	ず zu	つ tu	づ du	っ	ぬ nu	ふ hu	ぶ bu	ぷ pu	む mu	ゆ yu	ゅ lyu	る ru
ㅔ	え e	ぇ	け ke	げ ge	せ se	ぜ ze	て te	で de		ね ne	へ he	べ be	ぺ pe	め me			れ re
ㅗ	お o	ぉ	こ ko	ご go	そ so	ぞ zo	と to	ど do		の no	ほ ho	ぼ bo	ぽ po	も mo	よ yo	ょ lyo	ろ ro	を wo

	o	ㅋ	ㄱ	ㅅ	ㅈ	ㅌ	ㄷ	촉	ㄴ	ㅎ	ㅂ	ㅃ	ㅁ	야	ㄹ	와
ㅏ	ア a	ァ	カ ka	ガ ga	サ sa	ザ za	タ ta	ダ da		ナ na	ハ ha	バ ba	パ pa	マ ma	ヤ ya	ャ lya	ラ ra	ワ wa	ヮ lwa		ン n
l	イ i	ィ	キ ki	ギ gi	シ si	ジ zi	チ ti	ヂ di		ニ ni	ヒ hi	ビ bi	ピ pi	ミ mi			リ ri
ㅜ	ウ u	ゥ	ク ku	グ gu	ス su	ズ zu	ツ tu	ヅ du	ッ	ヌ nu	フ hu	ブ bu	プ pu	ム mu	ユ yu	ュ lyu	ル ru			ヴ vu
ㅔ	エ e	ェ	ケ ke	ゲ ge	セ se	ゼ ze	テ te	デ de		ネ ne	ヘ he	ベ be	ぺ pe	メ me			レ re
ㅗ	オ o	ォ	コ ko	ゴ go	ソ so	ゾ zo	ト to	ド do		ノ no	ホ ho	ボ bo	ポ po	モ mo	ヨ yo	ョ lyo	ロ ro	ヲ wo		ーー

독일어
ä	Ä	ö	Ö	ü	Ü	ß
프랑스어
á	à	Á	À	é	è	É	È	ç	Ç	ê
스페인어
à	á	Á	é	É	í	Í	Ó	ó	Ú	ú	Ñ	ñ	ä	Ä

Publication date	- (ex : 2010-2015)

FDA Approval Summary: Tucatinib with trastuzumab for advanced unresectable or metastatic, chemotherapy refractory, HER2 positive RAS wild type colorectal cancer

Academic Journal

Casak, S.J.; Horiba, M.N.; Yuan, M.; Cheng, J.; Lemery, S.J.; Li Shen, Y.; Fu, W.; Moore, J.N.; Li, Y.; Bi, Y.; Auth, D.; Fesenko, N.; Kluetz, P.G.; Pazdur, R.; Fashoyin-Aje, L.A.

In: Clinical Cancer Research. (Clinical Cancer Research, 1 November 2023, 29(21):4326-4330)

Full Text (ECC - 개별구독 전자저널) Web of Science JCR 저널정보 Scopus Find it@PNU

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement

Academic Journal

Patel, T.H.; Marcus, L.; Horiba, M.N.; Donoghue, M.; Lemery, S.J.; Pazdur, R.; Theoret, M.R.; Fashoyin-Aje, L.A.; Chatterjee, S.; Mishra-Kalyani, P.S.; Schuck, R.N.; Li, Y.; Zhang, X.; Zirkelbach, J.F.; Charlab, R.; Liu, J.; Yang, Y.

In: Clinical Cancer Research. (Clinical Cancer Research, 2023, 29(5):838-842)

Full Text (ECC - 개별구독 전자저널) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

FDA Approval Summary: Nivolumab for the Adjuvant Treatment of Adults with Completely Resected Esophageal/Gastroesophageal Junction Cancer and Residual Pathologic Disease

Academic Journal

Horiba, M.N.; Casak, S.J.; Mishra-Kalyani, P.S.; Roy, P.; Beaver, J.A.; Pazdur, R.; Kluetz, P.G.; Lemery, S.J.; Fashoyin-Aje, L.A.

In: Clinical cancer research : an official journal of the American Association for Cancer Research. (Clinical cancer research : an official journal of the American Association for Cancer Research, 15 December 2022, 28(24):5244-5248)

Full Text (ECC - 개별구독 전자저널) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer

Academic Journal

Catenacci, D.V.T.; Karrison, T.; Wallace, J.; Kozloff, M.; Xu, P.; Henderson, L.; Salgia, R.; Stadler, W.M.; Kindler, H.L.; Stiff, P.; Marsh, R.; Wade, J.; Kumar, P.; Junttila, M.R.; Wang, X.; De Sauvage, F.J.; Lenz, H.-J.; Bahary, N.; Horiba, M.N.; Nattam, S.R.; Rajdev, L.; Cohen, D.; Sleckman, B.; Takebe, N.

In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 20 December 2015, 33(36):4284-4292)

Full Text (ASCO/JCO) Web of Science JCR 저널정보 Scopus Find it@PNU

The Impact of a Feeding Jejunostomy in Nutritionally High Risk Patients Treated with Trimodality Therapy for Esophageal Cancer

Academic Journal

Reese, A.S.; Kim, G.J.; Battafarano, R.J.; Burrows, W.M.; Horiba, M.N.; Greenwald, B.D.; Suntharalingam, M.

In International Journal of Radiation Oncology, Biology, Physics 2011 81(2) Supplement:S317-S318

Full Text (ScienceDirect) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

The Benefit of Adjuvant Chemotherapy in Esophageal Cancer Patients with Residual Disease following Trimodality Therapy

Academic Journal

Kim, G.J.; Koshy, M.; Horiba, M.N.; Edelman, M.J.; Doyle, L.A.; Burrows, W.M.; Battafarano, R.J.; Krasna, M.J.; Hanlon, A.L.; Suntharalingam, M.

In International Journal of Radiation Oncology, Biology, Physics 2010 78(3) Supplement:S72-S73

Full Text (ScienceDirect) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin

Academic Journal

Vaishampayan, U.N.; Burger, A.M.; Li, J.; LoRusso, P.M.; Heilbrun, L.K.; Sausville, E.A.; Horiba, M.N.; Egorin, M.J.; Ivy, P.; Pacey, S.

In: Clinical Cancer Research. (Clinical Cancer Research, 15 July 2010, 16(14):3795-3804)

Full Text (ECC - 개별구독 전자저널) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

Glu-857 moderates K+-dependent stimulation and SCH 28080-dependent inhibition of the gastric H,K-ATPase

Academic Journal

Rulli, S.J.; Horiba, M.N.; Skripnikova, E.; Rabon, E.C.

In: Journal of Biological Chemistry. (Journal of Biological Chemistry, 21 May 1999, 274(21):15245-15250)

Full Text (ScienceDirect 종량제) Full Text (ScienceDirect O/A) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

부산대학교 도서관

Send an e-mail